Who makes better decisions: Neurologists or ChatGPT? A pooled analysis on therapeutic inertia in multiple sclerosis and neuromyelitis optica spectrum disorders

Key Points

• ChatGPT shows superior performance in addressing therapeutic inertia in multiple sclerosis disorders, especially in complex cases.
• The analysis reveals a significant difference with ChatGPT improving decision accuracy by 30% compared to neurologists.
• Using pooled data from multiple studies, the observational analysis focuses on decision-making metrics in neurological conditions.
• These findings may guide future clinical practices and highlight the potential of AI in enhancing treatment efficacy.